V
Vincent Mok
Researcher at The Chinese University of Hong Kong
Publications - 441
Citations - 20508
Vincent Mok is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Stroke & Dementia. The author has an hindex of 59, co-authored 406 publications receiving 15197 citations. Previous affiliations of Vincent Mok include Hong Kong Institute of Education & Tan Tock Seng Hospital.
Papers
More filters
Journal ArticleDOI
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
Joanna M. Wardlaw,Eric E. Smith,Geert J. Biessels,Charlotte Cordonnier,Franz Fazekas,Richard Frayne,Richard I. Lindley,John T. O'Brien,Frederik Barkhof,Oscar R. Benavente,Sandra E. Black,Carol Brayne,Monique M.B. Breteler,Hugues Chabriat,Charles DeCarli,Frank-Erik de Leeuw,Fergus N. Doubal,Marco Duering,Nick C. Fox,Steven M. Greenberg,Vladimir Hachinski,Ingo Kilimann,Vincent Mok,Robert J. van Oostenbrugge,Leonardo Pantoni,Oliver Speck,Blossom C. M. Stephan,Stefan J. Teipel,Anand Viswanathan,David J. Werring,Christopher Chen,Colin Smith,Mark A. van Buchem,Bo Norrving,Philip B. Gorelick,Martin Dichgans +35 more
TL;DR: This Position Paper summarises the main outcomes of this international effort to provide the STandards for ReportIng Vascular changes on nEuroimaging (STRIVE).
Journal ArticleDOI
Automatic Detection of Cerebral Microbleeds From MR Images via 3D Convolutional Neural Networks
TL;DR: This paper proposes a novel automatic method to detect CMBs from magnetic resonance (MR) images by exploiting the 3D convolutional neural network (CNN), outperforming previous methods using low-level descriptors or 2D CNNs by a significant margin.
Journal ArticleDOI
Six-Month Randomized, Placebo-Controlled, Double-Blind, Pilot Clinical Trial of Curcumin in Patients With Alzheimer Disease
Larry Baum,Christopher W.K. Lam,Stanley K.K. Cheung,Timothy Kwok,Victor W. C. Lui,Joshua Tsoh,Linda Lam,Vivian Yee-Fong Leung,Elsie Hui,Chelsia Ng,Jean Woo,Helen F.K. Chiu,William B. Goggins,Benny Zee,King-Fai Cheng,Carmen Yuet Shim Fong,Adrian Wong,Hazel Mok,Moses S. S. Chow,Ping Chuen Ho,Siu-Po Ip,Chung Shun Ho,Xiong Wen Yu,Caroline Yau Lin Lai,Ming Houng Chan,Samuel Szeto,Iris H.S. Chan,Vincent Mok +27 more
TL;DR: Curcumin is a polyphenolic molecule that comprises approximately 5% of turmeric, giving the spice its color but not flavor, and is used in processed foods as a yellow coloring.
Journal ArticleDOI
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Rik Ossenkoppele,Willemijn J. Jansen,Gil D. Rabinovici,Dirk L. Knol,Wiesje M. van der Flier,Bart N.M. van Berckel,Philip Scheltens,Pieter Jelle Visser,Sander C.J. Verfaillie,Marissa D. Zwan,Sofie Adriaanse,Adriaan A. Lammertsma,Frederik Barkhof,William J. Jagust,Bruce L. Miller,Howard J. Rosen,Susan M. Landau,Victor L. Villemagne,Christopher C. Rowe,Dong Y. Lee,Duk L. Na,Sang W. Seo,Marie Sarazin,Catherine M. Roe,Osama Sabri,Henryk Barthel,Norman Koglin,John R. Hodges,Cristian E. Leyton,Rik Vandenberghe,Koen Van Laere,Alexander Drzezga,Stefan Förster,Timo Grimmer,Pascual Sánchez-Juan,José M. Carril,Vincent Mok,Vincent Camus,William E. Klunk,Ann D. Cohen,Philipp T. Meyer,Sabine Hellwig,Andrew B. Newberg,Kristian Steen Frederiksen,Adam S. Fleisher,Mark A. Mintun,David A. Wolk,Agneta Nordberg,Juha O. Rinne,Gaël Chételat,Alberto Lleó,Rafael Blesa,Juan Fortea,Karine Madsen,Karen M. Rodrigue,David J. Brooks +55 more
TL;DR: Findings indicate the potential clinical utility of amyloid imaging for differential diagnosis in early-onset dementia and to support the clinical diagnosis of participants with AD dementia and noncarrier APOE ε4 status.
Journal ArticleDOI
Vascular dysfunction-The disregarded partner of Alzheimer's disease
Melanie D. Sweeney,Axel Montagne,Abhay P. Sagare,Daniel A. Nation,Lon S. Schneider,Helena C. Chui,Michael G. Harrington,Judy Pa,Meng Law,Danny J.J. Wang,Russell E. Jacobs,Fergus N. Doubal,Joel Ramirez,Sandra E. Black,Helene Benveniste,Martin Dichgans,Costantino Iadecola,Seth Love,Philip M.W. Bath,Philip M.W. Bath,Hugh S. Markus,Rustam Al-Shahi Salman,Stuart M. Allan,Terence J. Quinn,Rajesh N. Kalaria,David J. Werring,Roxana O. Carare,Rhian M. Touyz,Steve C.R. Williams,Michael A. Moskowitz,Zvonimir S. Katusic,Sarah E. Lutz,Orly Lazarov,Richard D. Minshall,Jalees Rehman,Thomas P. Davis,Cheryl L. Wellington,Hector M. González,Chun Yuan,Samuel N. Lockhart,Timothy M. Hughes,Christopher Chen,Perminder S. Sachdev,John T. O'Brien,Ingmar Skoog,Leonardo Pantoni,Deborah Gustafson,Geert Jan Biessels,Anders Wallin,Eric E. Smith,Vincent Mok,Adrian Wong,Peter Passmore,Frederick Barkof,Frederick Barkof,Majon Muller,Monique M.B. Breteler,Monique M.B. Breteler,Gustavo C. Román,Edith Hamel,Sudha Seshadri,Sudha Seshadri,Rebecca F. Gottesman,Mark A. van Buchem,Zoe Arvanitakis,Julie A. Schneider,Lester R. Drewes,Vladimir Hachinski,Caleb E. Finch,Arthur W. Toga,Joanna M. Wardlaw,Berislav V. Zlokovic +71 more
TL;DR: Vascular imaging biomarkers of small vessel disease of the brain, which is responsible for >50% of dementia worldwide, including AD, are already established, well characterized, and easy to recognize and should be incorporated into the AD Research Framework to gain a better understanding of AD pathophysiology and aid in treatment efforts.